The Covid-19 Clinical Trials Alliance aims to speed trials by matching research-enabled sites with study sponsors. Credit: mattthewafflecat from Pixabay.

Clinical research sites network Care Access Research has launched the Covid-19 Clinical Trials Alliance to connect sites, sponsors and CROs to accelerate coronavirus trials.

The strategic collaboration is aimed at accelerating tests, treatment, and vaccines for the deadly virus.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

According to Care Access Research, the healthcare industry is currently in urgency to increase the number of sites that are capable of running efficient Covid-19 trials.

Care Access Research CEO and co-founder Ahmad Namvargolian said: “The industry needs swift collaboration like never before. It is critical for study sponsors to find clinical trial sites fast enough to avoid delays in trials. Each day lost means lives lost.

“Now more than ever, the industry needs the ability to quickly connect research-capable clinics and hospitals with trial sponsors looking for them. This alliance gives sponsors a simple way to connect with sites around the globe to run their Covid-19 trials.”

The Covid-19 Clinical Trials Alliance aims to speed up trials by matching research-enabled sites with study sponsors.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The plan is that, by making hundreds of sites available in one place to Covid-19 studies, participants will be able to cut out the months-long lag when looking for research sites for studies.

As part of this work for the joint alliance, Care Access Research will provide support services to sites that are interested to run coronavirus studies but lack the necessary infrastructure associated with it.

Salt Lake City gastroenterologist and principal investigator Peder J. Pedersen said: “Care Access Research has been a fantastic partner in preparing our site to run Covid-19 trials.

“While we focus primarily on GI studies at our site, we want to contribute to the Covid-19 response. Care Access Research has made it possible for us to do that.”